Country: Malta
Language: English
Source: Medicines Authority
PANTOPRAZOLE SODIUM, SESQUIHYDRATE
Aurobindo Pharma (Malta) Limited Vault 14, Level 2, Valletta Waterfront, Floriana FRN 1913, Malta
A02BC02
PANTOPRAZOLE SODIUM SESQUIHYDRATE 40 mg
GASTRO-RESISTANT TABLET
PANTOPRAZOLE SODIUM SESQUIHYDRATE 40 mg
POM
DRUGS FOR ACID RELATED DISORDERS
Authorised
2014-07-15
Page 1 of 7 PACKAGE LEAFLET: INFORMATION FOR THE USER PANTOPRAZOLE 40 MG GASTRO-RESISTANT TABLETS Pantoprazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Pantoprazole is and what it is used for 2. What you need to know before you take Pantoprazole 3. How to take Pantoprazole 4. Possible side effects 5. How to store Pantoprazole 6. Contents of the pack and other information 1. WHAT PANTOPRAZOLE IS AND WHAT IT IS USED FOR Pantoprazole contains the active substance pantoprazole. Pantoprazole is a selective “proton pump inhibitor”, a medicine which reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine. _Pantoprazole is used to treat Adults and adolescents 12 years of age and above for: _ - Reflux oesophagitis .An inflammation of your oesophagus (the tube which connects your throat to your stomach) accompanied by the regurgitation of stomach acid. _Pantoprazole is used to treat Adults for: _ - An infection with a bacterium called _Helicobacter pylori _ in patients with duodenal ulcers and stomach ulcers in combination with two antibiotics (Eradication therapy). The aim is to get rid of the bacteria and so reduce the likelihood of these ulcers returning. - Stomach and duodenal ulcers. - Zollinger-Ellison-Syndrome and other conditions producing too much acid in the stomach. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PANTOPRAZOLE DO NOT TAKE PANTOPRAZOLE - If you are allergic to pantoprazole or to any of the other ingredien Read the complete document
Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Pantoprazole 40 mg gastro-resistant tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 40 mg pantoprazole (as pantoprazole sodium sesquihydrate). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Gastro-resistant tablet. Yellow colored, enteric coated oval biconvex tablets plain on both the sides. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pantoprazole is indicated for use in Adults and adolescents 12 years of age and above for _ _ • Reflux oesophagitis. Pantoprazole is indicated for use in Adults for _ _ • Eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with H. pylori associated ulcers. • Gastric and duodenal ulcer. • Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Adults and adolescents 12 years of age and above _ _ _Reflux oesophagitis _ One tablet of Pantoprazole per day. In individual cases the dose may be doubled (increase to 2 tablets Pantoprazole daily) especially when there has been no response to other treatment. A 4-week period is usually required for the treatment of reflux oesophagitis. If this is not sufficient, healing will usually be achieved within a further 4 weeks. _Adults _ _Eradication of H. pylori in combination with two appropriate antibiotics _ In H. pylori positive patients with gastric and duodenal ulcers, eradication of the germ by a combination therapy should be achieved. Considerations should be given to official local guidance (e.g. national recommendations) regarding bacterial resistance and the appropriate use and prescription of antibacterial agents. Depending upon the resistance pattern, the following combinations can be recommended for the eradication of H. pylori: Page 2 of 12 a) twice daily one tablet Pantoprazole + twice daily 1000 mg amoxicillin + twice daily 500 mg clarithromyc Read the complete document